US5723592A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Parallel selex
Assignee: MEDALLION BIOMEDICAL LLC
•
Filing: 1995-06-05
•
Granted: 1998-03-03
•
Expires: 2015-06-05
Abstract
Abstract This invention discloses a method for coevolving products from two or more reactants, along with the nucleic acid that can facilitate the reaction for making the products. The invention further discloses the products and facilitating nucleic acids produced by said method.
Inventors
- 👤 Bruce E. Eaton
- 👤 Larry Gold
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 12:45
CPC Classifications
C; C07; C07H; C07H21/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/547; A61K47/549; B; B82; B82Y; B82Y5/00; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07K; C07K14/00; C07K14/001; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1034; C12N15/1048; C12N15/11; C12N15/115; C12N9/00; C12N9/10; C12N9/12; C12N9/1241; C12N9/1276; C12Q; C12Q1/00; C12Q1/34; C12Q1/37; C12Q1/68; C12Q1/6811; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535; G01N33/569; G01N33/56983; G01N33/56988; G01N33/68; G01N33/6803; G01N33/6842; G01N33/74; G01N33/76; C12N2310/00; C12N2310/10; C12N2310/13; C12N2310/30; C12N2310/32; C12N2310/322; C12N2310/50; C12N2310/53; C40; C40B; C40B40/00; F; F02; F02B; F02B75/00; F02B75/02; F02B2075/022; F02B2075/027; G01N2333/00; G01N2333/005; G01N2333/08; G01N2333/15; G01N2333/155; G01N2333/16; G01N2333/163; G01N2333/435; G01N2333/475; G01N2333/50; G01N2333/503; G01N2333/575; G01N2333/62; G01N2333/81; G01N2333/8107; G01N2333/811; G01N2333/8121; G01N2333/8125; G01N2333/90; G01N2333/914; G01N2333/948; G01N2333/95; G01N2333/964; G01N2333/96425; G01N2333/96427; G01N2333/9643; G01N2333/96433; G01N2333/96436; G01N2333/96441; G01N2333/96455; G01N2333/96486; G01N2333/966; G01N2333/972; G01N2333/9726; G01N2333/974; G01N2333/976
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
92 words
A non-naturally occurring facilitating nucleic acid that facilitates a bond formation reaction between a first reactant and a free reactant, wherein said bond formation reaction is selected from the group consisting of a condensation reaction, a hydrolysis reaction, a cycloaddition reaction, a conjugate addition reaction, an aldol condensation reaction, a cyclopropanation reaction, a hydrogenation reaction, and a cyclotrimerization reaction, wherein each reactant is comprised of a small organic molecule with a molecular weight in the range of 2 to 1000, and further wherein said first reactant is coupled to said nucleic acid.
Claim 2
Dependent Claim
92 words
A non-naturally occurring facilitating nucleic acid that facilitates a bond formation reaction between a first reactant and a free reactant, wherein said bond formation reaction is selected from the group consisting of a condensation reaction, a hydrolysis reaction, a cycloaddition reaction, a conjugate addition reaction, an aldol condensation reaction, a cyclopropanation reaction, a hydrogenation reaction, and a cyclotrimerization reaction, wherein each reactant is comprised of a small organic molecule with a molecular weight in the range of 2 to 1000, and further wherein said first reactant is coupled to said nucleic acid.
Claim 3
Dependent Claim
100 words
A non-naturally occurring facilitating nucleic acid which increases the reaction rate of a bond formation reaction to form a product from a first reactant and a free reactant, wherein said bond formation reaction is selected from the group consisting of a condensation reaction, a hydrolysis reaction, a cycloaddition reaction, a conjugate addition reaction an aldol condensation reaction, a cyclopropanation reaction, a hydrogenation reaction, and a cyclotrimerization reaction, wherein each reactant is comprised of a small organic molecule with a molecular weight in the range of 2 to 1000, and further wherein said first reactant is coupled to said nucleic acid.
Claim 4
Dependent Claim
100 words
A non-naturally occurring facilitating nucleic acid which increases the reaction rate of a bond formation reaction to form a product from a first reactant and a free reactant, wherein said bond formation reaction is selected from the group consisting of a condensation reaction, a hydrolysis reaction, a cycloaddition reaction, a conjugate addition reaction an aldol condensation reaction, a cyclopropanation reaction, a hydrogenation reaction, and a cyclotrimerization reaction, wherein each reactant is comprised of a small organic molecule with a molecular weight in the range of 2 to 1000, and further wherein said first reactant is coupled to said nucleic acid.
Claim 5
Dependent Claim
25 words
The facilitating nucleic acid of claim 1 wherein the nucleic acid is selected from the group consisting of single-stranded RNA, single-stranded DNA, and double-stranded DNA.
Claim 6
Dependent Claim
25 words
The non-naturally nucleic acid of claim 1 wherein the nucleic acid is selected from the group consisting of single-stranded RNA, single-stranded DNA, and double-stranded DNA.
References Cited (Backward Citations)
GB2183661A
Cited
US4794073A
Cited
WO1991014696A1
Cited
WO1991019813A1
Cited
US5270163A
Cited
WO1992014843A1
Cited
WO1995016788A1
Cited
WO1996006944A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-03-02 | 2001-09-01 | 2002-03-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-03-02 | 2005-09-01 | 2006-03-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-03-02 | 2009-09-01 | 2010-03-03 | $7700.00 | Window Closed / Lapsed |